Peura, J.
1138  Ergebnisse:
Personensuche X
?
2

Risk aversion affects economic values of blue fox breeding ..:

Peura, J. ; Kempe, R. ; Strandén, I..
Journal of Animal Breeding and Genetics.  133 (2016)  6 - p. 485-492 , 2016
 
?
3

The effects of increasing body mass index on heartburn seve..:

Peura, D. A. ; Pilmer, B. ; Hunt, B...
Alimentary Pharmacology & Therapeutics.  37 (2013)  8 - p. 810-818 , 2013
 
?
4

Profitable blue fox production: Economic values for Finnish..:

Peura, J. ; Strandén, I. ; Mäntysaari, E. A.
Acta Agriculturae Scandinavica, Section A - Animal Science.  63 (2013)  1 - p. 2-9 , 2013
 
?
5

Distinguishing the impact of dexlansoprazole on heartburn v..:

Peura, D. A. ; Pilmer, B. ; Hunt, B...
Alimentary Pharmacology & Therapeutics.  38 (2013)  10 - p. 1303-1311 , 2013
 
?
6

Risk factors associated with a decrease ≥2 g/dL in haemoglo..:

Lanas, A. ; Goldstein, J. L. ; Chan, F. K. L....
Alimentary Pharmacology & Therapeutics.  36 (2012)  5 - p. 485-492 , 2012
 
?
7

Commentary: risk factors for gastrointestinal bleeding in N..:

Lanas, A. ; Goldstein, J. ; Chan, F. K. L....
Alimentary Pharmacology & Therapeutics.  36 (2012)  9 - p. 905-905 , 2012
 
?
9

Haemoglobin decreases in NSAID users over time: an analysis..:

Goldstein, J. L. ; Chan, F. K. L. ; Lanas, A....
Alimentary Pharmacology & Therapeutics.  34 (2011)  7 - p. 808-816 , 2011
 
?
10

The 12-month safety profile of dexlansoprazole, a proton pu..:

Dabholkar, A. H. ; Han, C. ; Paris, M. M....
Alimentary Pharmacology & Therapeutics.  33 (2010)  3 - p. 366-377 , 2010
 
?
 
?
12

Changes of gastric histology in patients with erosive oesop..:

Haber, M. M. ; Hunt, B. ; Freston, J. W....
Alimentary Pharmacology & Therapeutics.  32 (2010)  1 - p. 83-96 , 2010
 
?
13

Clinical trials: healing of erosive oesophagitis with dexla..:

SHARMA, P. ; SHAHEEN, N. J. ; PEREZ, M. C....
Alimentary Pharmacology & Therapeutics.  29 (2009)  7 - p. 731-741 , 2009
 
?
14

Safety profile of dexlansoprazole MR, a proton pump inhibit..:

PEURA, D. A. ; METZ, D. C. ; DABHOLKAR, A. H....
Alimentary Pharmacology & Therapeutics.  30 (2009)  10 - p. 1010-1021 , 2009
 
?
15

Clinical trial: lansoprazole 15 or 30 mg once daily vs. pla..:

PEURA, D. A. ; RIFF, D. S. ; SNODDY, A. M..
Alimentary Pharmacology & Therapeutics.  30 (2009)  5 - p. 459-468 , 2009
 
1-15